Gastroenteropancreatic endocrine tumors: Effect of Sandostatin® on tumor growth

This publication has 15 references indexed in Scilit:

• Therapeutic strategies in the management of endocrine GEP tumours
  European Journal of Clinical Investigation, 1990
• Recombinant α-2 Interferon with or Without Hepatic Artery Embolization in the Treatment of Midgut Carcinoid Tumours a Preliminary Report
  Acta Oncologica, 1989
• Prospective study of chemotherapy in patients with metastatic gastrinoma
  Gastroenterology, 1988
• Tumor regression of an ileal carcinoid under the treatment with the somatostatin analogue SMS 201–995
  Journal of Molecular Medicine, 1988
• TREATMENT OF MALIGNANT ENDOCRINE PANCREATIC TUMOURS WITH HUMAN LEUCOCYTE INTERFERON
  The Lancet, 1986
• THERAPEUTIC EMBOLISATION OF THE HEPATIC ARTERY: A REVIEW OF 75 PROCEDURES
  The Lancet, 1985
• Long-Term Treatment of a VIPoma With Somatostatin Analogue Resulting in Remission of Symptoms and Possible Shrinkage of Metastases
  Gastroenterology, 1985
• Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor.
  Journal of Clinical Oncology, 1984
• Effects of Leukocyte Interferon on Clinical Symptoms and Hormone Levels in Patients with Mid-Gut Carcinoid Tumors and Carcinoid Syndrome
  New England Journal of Medicine, 1983
• Streptozocin Alone Compared with Streptozocin plus Fluorouracil in the Treatment of Advanced Islet-Cell Carcinoma
  New England Journal of Medicine, 1980